Whales with a lot of money to spend have taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli ...

Eli Lilly (NYSE:LLY) is making a $5.3 billion investment to expand manufacturing for its high-demand anti-obesity drug Zepbound ...

Eli Lilly and Incyte's baricitinib showed significant hair regrowth in adolescents with severe alopecia areata, with results ...

Pfizer, Inc. (NYSE:PFE) reportedly said in a statement that it will end R&D efforts in the Alzheimer’s and Parkinson’s disease... Merck & Co., Inc. (NYSE:MRK) announced that its anti-PD-1 ...

A major pharmaceutical company that has invested heavily in North Carolina is planning multiple new factories in the U.S. STORY HIGHLIGHTS Eli Lilly plans $27 billion U.S. expansion, will create ...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story ...

Amneal Pharmaceuticals, Inc. offers strong growth prospects with undervalued stock, rising revenues, reduced debt, and key ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

After scoring a long-awaited FDA approval last fall, Eli Lilly has launched a consumer-facing campaign to get the word out ...

Eli Lilly shareholders can take confidence from the fact that EBIT margins are up from 32% to 39%, and revenue is growing. That's great to see, on both counts. In the chart below, you can see how ...

Volume & Open Interest Trends In terms of liquidity and interest, the mean open interest for Eli Lilly options trades today is 402.8 with a total volume of 21,398.00. In the following chart ...